Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2007

01-03-2007

Papillary Lesions: A Review of the Literature

Authors: Edna K. Valdes, MD, Sheldon M. Feldman, MD, FACS, Susan K. Boolbol, MD

Published in: Annals of Surgical Oncology | Issue 3/2007

Login to get access

Excerpt

Papillary lesions of the mammary glands are relatively uncommon. These lesions account for less than 10% of benign breast neoplasms, 0.5–2% of all breast malignancies,1 and up to 5% of all the lesions undergoing biopsy.2 They comprise a broad spectrum of entities such as papilloma, papillomatosis, sclerosing papilloma, atypical papilloma, papilloma with atypical ductal hyperplasia, intraductal papillary carcinoma and invasive papillary carcinoma.2‐8 Distinguishing benign from malignant lesions can be quite challenging without surgical excision because of the lack of distinctive clinical and radiological signs. Overall, clear management guidelines regarding papillary lesions have not yet been established. …
Literature
1.
Masood S, Loya A, Khalbuss W. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Diagn Cytopathol 2003; 28(6):329–34PubMedCrossRef
2.
Rosen EL, Bentley RC, Baker JA, Soo MS. Imaging-guided core needle biopsy of papillary lesions of the breast. AJR Am J Roentgenol 2002; 179:1185–92PubMed
3.
Puglisi F, Zuiani C, Bazzocchi M, et al. Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions. Oncology 2003; 65:311–5PubMedCrossRef
4.
Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia. Can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol 2004; 122:440–3PubMedCrossRef
5.
Mercado CL, Hamele-Bena D, Singer C, Koenigsberg T, Pile-Spellman E, Higgins H, Smith SJ. Papillary lesions of the breast: Evaluation with stereotactic directional vacuum-assisted biopsy. Radiology 2001; 221:650–5PubMed
6.
Simsir A, Waisman J, Thorner K, Cangiarella J. Mammary lesions diagnosed as “papillary” by aspiration biopsy. 70 cases with follow-up. Cancer 2003; 99:156–65PubMedCrossRef
7.
Ivan D, Selinko V, Sahin AA, Sneige N, Middleton LP. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: Histologic predictors of malignancy. Mod Pathol 2004; 17:165–71PubMedCrossRef
8.
Jacobs TW, Connolly JL. Nonmalignant lesions in breast core needle biopsies. To excise or not to excise? Am J Surg Pathol 2002; 26(9):1095–110PubMedCrossRef
9.
Hoda SA, Rosen PP. Practical considerations in the pathologic diagnosis of needle core biopsies of breast. Am J Clin Pathol 2002; 118:101–8PubMedCrossRef
10.
11.
Liberman L, Bracero N, Vuolo MA, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Percutaneous large-core biopsy of papillary breast lesions. AJR Am J Roentgenol 1999; 172:331–7PubMed
12.
Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin N Am 2000; 38(4):791–807PubMedCrossRef
13.
14.
Gomez-Aracil V, Mayayo E, Azua J, Arraiza A. Papillary neoplasms of the breast: Clues in fine needle aspiration cytology. Cytopathology 2002; 13:22–30PubMedCrossRef
15.
Gendler LS, Feldman SM, Balassanian R, et al. Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy. Am J Surg 2004; 188:365–70PubMedCrossRef
16.
Valdes EK, Tartter PI, Genelus-Dominique E, Guilbaud DA, Rosenbaum-Smith S, Estabrook A. The significance of papillary lesions at percutaneous breast biopsy. Ann Surg Oncol 2006; 13(4):480–2PubMedCrossRef
17.
Jeffrey PB, Ljung BM. Benign and malignant papillary lesions of the breast. A cytomorphologic study. Am J Clin Pathol 1994; 101:500–7PubMed
18.
Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens. Risk of carcinoma in subsequent excision. Am J Clin Pathol 2004; 122:217–21PubMedCrossRef
19.
Hermann G, Mester J, Drossman SR, Jaffer S, Bleiweiss IJ, Feig SA. The role of core biopsy in the evaluation of intraductal papilloma of the breast: Radiologic-pathologic correlation (abstract). Radiology 2002; 225:460
20.
Berg WA, Berg AP, Ioffe OB. Initial success and frequency of rebiopsy after ultrasound-guided 14-gauge core breast biopsy (abstract). AJR Am J Roentgenol 2003; 180:10
21.
Saddik M, Lai R. CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast. J Clin Pathol 1999; 52:862–4PubMedCrossRef
22.
Mosunjac MB, Lewis MM, Lawson D, Cohen C. Use of a novel marker, calponin, for myoepithelial cells in fine needle aspirates of papillary breast lesions. Diagn Cytopathol 2000; 23:151–5PubMedCrossRef
23.
Berg WA. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin N Am 2004; 42:935–46PubMedCrossRef
24.
Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: Clinical importance. Radiology 2000; 216:831–7PubMed
25.
Michael CW, Buschmann B. Can true papillary neoplasms of breast and their mimickers be accurately classified by cytology? Cancer 2002; 96(2):92–100PubMedCrossRef
Metadata
Title
Papillary Lesions: A Review of the Literature
Authors
Edna K. Valdes, MD
Sheldon M. Feldman, MD, FACS
Susan K. Boolbol, MD
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9170-1

Other articles of this Issue 3/2007

Annals of Surgical Oncology 3/2007 Go to the issue

OriginalPaper

Outcome After Hepatectomy for Multiple (Four or More) Colorectal Metastases in the Era of Effective Chemotherapy

OriginalPaper

Role of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal Cancer

OriginalPaper

Intra-operative Touch Preparation Cytology; Does It Have a Role in Re-excision Lumpectomy?

OriginalPaper

Association of Clinical and Pathologic Variables with Lumpectomy Surgical Margin Status after Preoperative Diagnosis or Excisional Biopsy of Invasive Breast Cancer

OriginalPaper

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis

OriginalPaper

Comparison Between Local Ablative Therapy and Chemotherapy for Non-Resectable Colorectal Liver Metastases: A Prospective Study